Sanofi SA continued its transition to a company focused on specialty care in the first half year, but sales from new products were not sufficient to offset declines from the company’s traditional franchises. Net sales for the second quarter were €8.2 billion, down by 5.7% from a year earlier. For the first half they were €16.1 billion, down by 7.2%. Operating profit for the quarter was €961 million, down by 30%, and for the first-half it was €2.2 billion, down by 30%. Both sets of figures conform with International Financial Reporting Standards (IFRS).
